TrialClinical drug investigation2012

A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.

Seung Jae Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.